KATONAH, NY
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)SALLA TREATMENT AND RESEARCH FOUNDATION INC, founded in 2018, is a small nonprofit in the Diseases & Disorders sector that reported $234K in total revenue in fiscal year 2024. Revenue grew 9% year-over-year, indicating healthy expansion. The organization ran a surplus of $82K, a strong 35% operating margin.
TO SUPPORT AND ADVANCE SALLA DISEASE TREATMENTS, RESEARCH, EDUCATION, AWARENESS, AND FAMILY NETWORKS.
4B: ONGOING SCIENTIFIC SUPPORT: THE FOUNDATION CONTINUES TO SUPPORT COLLABORATIVE SCIENTIFIC RESEARCH VIA GRANTS TO ACCELERATE THE PROSPECTS OF EFFECTIVE MEDICAL TREATMENTS AND PROMOTE SCIENTIFIC...
4B: ONGOING SCIENTIFIC SUPPORT: THE FOUNDATION CONTINUES TO SUPPORT COLLABORATIVE SCIENTIFIC RESEARCH VIA GRANTS TO ACCELERATE THE PROSPECTS OF EFFECTIVE MEDICAL TREATMENTS AND PROMOTE SCIENTIFIC DISCOVERY FOR SALLA DISEASE/FREE SIALIC ACID STORAGE DISORDERS. ALL SCIENTIFIC GRANT PROPOSALS ARE REVIEWED BY THE FOUNDATIONS INDEPENDENT SCIENTIFIC ADVISORY BOARD (SAB). THE SAB THEN PROVIDES INPUT TO STARS BOARD OF DIRECTORS. IN 2024, STAR PROVIDED FUNDS TO RESEARCHERS AT CHILDRENS HOSPITAL OF ORANGE COUNTY CALIFORNIA (USA)$10,000; LE CENTRE NATIONAL DE LA RECHERCHE SCIENTIFQUE, PARIS (FRANCE) $56,383; AND NATIONAL INSTITUTES OF HEALTH (USA) $45,000; AND SUPPORTED A PATIENT REGISTRY $2,100.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $233,871 | $214,738 | +0.1% |
| Expenses | $151,543 | $125,940 | +0.2% |
| Net Income | $82,328 | $88,798 | -0.1% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| ADAM LEBLANC | BOARD MEMEBER | 2.00 |
Director
|
$0 | $0 | $0 |
| KATHRINE ROA | BOARD MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| JESSICA KLEIN FOGLIO | PRESIDENT | 15.00 |
Officer
Director
|
$0 | $0 | $0 |
| MICHAEL FOGLIO | VICE PRESIDENT | 5.00 |
Officer
Director
|
$0 | $0 | $0 |
| DAVID HALPERN | SECRETARY | 2.00 |
Officer
Director
|
$0 | $0 | $0 |
| KENNETH KLEIN | TREASURER | 5.00 |
Officer
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | No data | No data | No data | No data |
| 2024 | $233,871 | $151,543 | $258,554 | $82,328 |
| 2023 | $214,738 | $125,940 | $176,226 | $88,798 |
| 2022 | $66,946 | $125,034 | $68,023 | $-58,088 |
| 2021 | $82,490 | $112,617 | $95,141 | $-30,127 |
| 2020 | $120,626 | $114,423 | $125,268 | $6,203 |
Compare SALLA TREATMENT AND RESEARCH FOUNDATION INC with other nonprofits in New York and across the country.